Literature DB >> 9877158

Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics.

M Hult1, H Jörnvall, U C Oppermann.   

Abstract

Functional analyses were performed with microsomal human 11beta-hydroxysteroid dehydrogenase type 1 overexpressed in the yeast Pichia pastoris. Cell extracts or microsomes from transformed strains displayed dehydrogenase and reductase activities, which were up to 10 times higher than in human liver microsomes, while for whole cells cortisone reduction but no dehydrogenase activity was observed. The synthetic glucocorticoids prednisolone and prednisone were efficiently metabolized by subcellular fractions, whereas no activity was observed with dexamethasone, budesonide and deflazacort. Inhibitors found to be effective towards the recombinant 11beta-hydroxysteroid dehydrogenase include synthetic steroids and xenobiotic compounds, revealing selective inhibition of the reaction direction, useful for development of specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877158     DOI: 10.1016/s0014-5793(98)01515-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.

Authors:  Arne Meyer; Anna Vuorinen; Agnieszka E Zielinska; Petra Strajhar; Gareth G Lavery; Daniela Schuster; Alex Odermatt
Journal:  Drug Metab Dispos       Date:  2013-06-26       Impact factor: 3.922

3.  Bupropion metabolism by human placenta.

Authors:  Xiaoming Wang; Doaa R Abdelrahman; Olga L Zharikova; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2010-01-28       Impact factor: 5.858

Review 4.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

5.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

6.  Yeast-based assays for screening 11β-HSD1 inhibitors.

Authors:  Rosario Vanella; Roberta Callari; Anna Weston; Harald Heider; Markus S Schwab; Eric Kübler
Journal:  Microb Cell Fact       Date:  2016-03-15       Impact factor: 5.328

7.  Hydroxysteroid dehydrogenase HSD1L is localised to the pituitary-gonadal axis of primates.

Authors:  A Daniel Bird; Spencer Greatorex; David Reser; Gareth G Lavery; Timothy J Cole
Journal:  Endocr Connect       Date:  2017-10       Impact factor: 3.335

8.  Effect of deflazacort on pregnancy outcome in kidney transplant patients: should we change the immunosuppressant before conception?

Authors:  Bo Hyon Yun; Dong Jin Joo; Seok Kyo Seo; Si Hyun Cho; Young Sik Choi; Byung Seok Lee
Journal:  BMC Nephrol       Date:  2019-05-14       Impact factor: 2.388

9.  Effects of HSD11B1 knockout and overexpression on local cortisol production and differentiation of mesenchymal stem cells.

Authors:  Angelique Kragl; Janosch Schoon; Ana Tzvetkova; Christoph Wenzel; Martina Blaschke; Wolfgang Böcker; Heide Siggelkow; Mladen V Tzvetkov
Journal:  Front Bioeng Biotechnol       Date:  2022-08-25

Review 10.  Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds.

Authors:  Marjan Nassiri Asl; Hossein Hosseinzadeh
Journal:  Phytother Res       Date:  2008-06       Impact factor: 5.878

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.